Get our latest weight-loss and health guides straight to your inbox.
Wegovy: evidence, safety and questions for your prescriber
Wegovy contains semaglutide, a prescription-only medicine used for weight management alongside nutrition and physical activity. This guide explains questions to raise with a prescriber rather than recommending a medicine for everyone.
What does Wegovy do?
Semaglutide acts at GLP-1 receptors and can help regulate appetite. Clinical-trial averages do not predict one person’s outcome. Ask which findings apply to people with your health history and what a meaningful benefit would look like for you.
Who may be considered?
The adult weight-management indication includes an initial BMI of at least 30, or at least 27 with a weight-related health condition. A clinician must also consider your medical history, other medicines, pregnancy plans and whether treatment is appropriate. The licence and a service’s own assessment criteria are different things.
Understand the safety plan
Gastrointestinal effects such as nausea, vomiting, diarrhoea and constipation can occur. Symptoms are not always mild. Discuss symptoms that persist, affect drinking or interfere with daily life. Severe, persistent abdominal pain needs urgent medical assessment. Read the leaflet supplied with your medicine for the full warnings and instructions.
Prepare for a consultation
- Bring your medicine list, health history and previous treatment details.
- Discuss expected benefits, risks, costs and practical follow-up.
- Agree what to do if treatment is not tolerated or is not meeting your goals.
Read about our weight-management service. Reference: UK Wegovy product information.
Secure Checkout
Fast Shipping
Easy Returns